82
Participants
Start Date
October 1, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
October 1, 2028
Titrated weaning of vasopressin.
The titrated group will follow the vasopressin weaning protocol used in the DOVSS study (reduction of 0.01 U/min per hour).
Abrupt weaning of vasopressin.
The abrupt group will discontinue the vasopressin infusion at the time of randomization, without dose titration.
Hospital Nossa Senhora da Conceicao
OTHER